For
a company that sold Wall Street on a pretty aggressive set of
expectations, St.
Jude Medical
(NYSE:STJ)
is certainly seeing the other side of the momentum trade. Worries
about the company's pipeline and competitive positioning would be bad
enough in their own right, but ongoing worries about the company's
high-voltage leads threaten not only the company's valuation but also
its competitive standing.
Please click here for more:
http://www.investopedia.com/
No comments:
Post a Comment